Melanoma Clinical Trials in Philadelphia

Showing 301-320 of 326 trials

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

NCT00671918

Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) for Navidea's Lymphoseek for use in intraoperative localization of lymph tissue (nodes) in the lymphatic pathway draining the primary site of a tumor.

Breast CancerMelanoma

Navidea Biopharmaceuticals186 participantsStarted Apr 2008

Alexander City, Alabama, United States • Birmingham, Alabama, United States • La Jolla, California, United States +12 more locations

COMPLETEDPhase 1< 1 mile

Vaccine Therapy in Treating Patients With Stage IV Melanoma

NCT00003665

Randomized phase I trial to study the effectiveness of vaccine therapy in treating patients who have stage IV melanoma. Vaccines may make the body build an immune response to kill tumor cells.

Melanoma (Skin)

National Cancer Institute (NCI)40 participantsStarted Apr 1999

Philadelphia, Pennsylvania, United States

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Melanoma Trials in Other Cities

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Study of CP-675,206 in Refractory Melanoma

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Study of XL281 in Adults With Solid Tumors

Phase II Trial of Allovectin-7® for Metastatic Melanoma

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

A Study of Volociximab in Metastatic Melanoma

Other Conditions in Philadelphia